Weybosset Research & Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian National Railway
CNI
|
+$10.8M |
| 2 |
Aptiv
APTV
|
+$9.82M |
| 3 |
Apple
AAPL
|
+$733K |
| 4 |
RH
RH
|
+$574K |
| 5 |
Expeditors International
EXPD
|
+$508K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$232K |
| 2 |
3M
MMM
|
+$207K |
| 3 |
Kopin
KOPN
|
+$175K |
| 4 |
Keysight
KEYS
|
+$116K |
| 5 |
Copart
CPRT
|
+$25.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 37.67% |
| 2 | Technology | 18.47% |
| 3 | Financials | 15.2% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Healthcare | 8.41% |
Similar funds
Weybosset Research & Management's Q3 2022 Portfolio in Review
As of Q3 2022, Weybosset Research & Management held 56 positions worth $227M, up 12% from $202M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Weybosset Research & Management deployed $27.3M of net new capital in Q3 2022, opening 8 new positions and adding to 32 existing holdings. Its largest new stake was Canadian National Railway: 90,272 shares worth $9.75M.
By sector, the portfolio is most concentrated in Industrials at 38% of assets, up from 36% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Keysight, an estimated $116K trimmed.
- Weybosset Research & Management's largest Q3 2022 buy was Canadian National Railway: 90,272 shares worth $9.75M.
- Weybosset Research & Management added most to Apple in Q3 2022, an estimated $733K increase.
- Weybosset Research & Management's biggest Q3 2022 reduction was Keysight, cutting an estimated $116K.
- Weybosset Research & Management fully exited McDonald's in Q3 2022, selling an estimated $232K.
- Weybosset Research & Management's ten largest holdings make up 57% of its $227M portfolio in Q3 2022.
- Weybosset Research & Management opened 8 new positions and closed 3 in Q3 2022.
- Weybosset Research & Management's portfolio value rose 12% quarter-over-quarter to $227M.
Based on Weybosset Research & Management's 13F filing for Q3 2022, filed 7 Nov 2022.